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Introduction: Gallbladder polyps (GBPs) are a common incidental ﬁnding on ultrasound (US) examina-
tion. The malignant potential of GBPs is debated, and there is limited guidance on surveillance. This
systematic review sought to assess the natural history of ultrasonographically diagnosed GBPs and their
malignant potential.
Methods: The keywords: “Gallbladder” AND (“polyp” OR “polypoid lesion”) were used to conduct a
search in four reference libraries to identify studies which examined the natural history of GBPs diag-
nosed by US. Twelve studies were eligible for inclusion in this review.
Results: Of the 5482 GBPs reported, malignant GBPs had an incidence of just 0.57%. True GBPs had an
incidence of 0.60%. Sixty four patients of adenomatous and malignant polyps were reported. Only in one
patient was a malignant GBP reported to be <6mm. Risk factors associated with increased risk of ma-
lignancy were GBP >6mm, single GBPs, symptomatic GBPs, age >60 years, Indian ethnicity, gallstones
and cholecystitis.
Conclusion: With the reported incidence of GBP malignancy at just 0.57%, a management approach based
on risk assessment, clear surveillance planning, and multi disciplinary team (MDT) discussion should be
adopted. The utilization of endoscopic ultrasound(EUS) should be Only considered on the grounds of its
greater sensitivity and speciﬁcity when compared to US scans.
© 2016 IJS Publishing Group Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
The incidental detection of gallbladder polyps (GBPs) is more
frequently being reported as the use and the quality of ultrasoundl scientiﬁc meeting, Brighton,
al Medicine, Ashton Street,
(M. Elmasry).
by Elsevier Ltd. All rights reserve(US) scanning increases [1e4]. The term GBPs or polypoid lesions of
the gallbladder refers to any elevated lesion of the mucosal surface
of the gallbladder wall. These polyps have been classiﬁed into
adenomatous polyps, pseudotumours and malignant polyps
[5e7].Evidence suggests that adenomas (an example of a “true
tumours”) have malignant potential, though this is a subject of
debate, with conﬂicting opinions on the validity of an adenoma-
adenocarcinoma pathway [8e11].
Polyps are incidentally detected in 0.3e12.3% of patients who
undergo ultrasonography (US) of the gallbladder, ord.
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is small but signiﬁcant, with previous studies suggesting between 3
and 8% of all GBPs are malignant [26,27]. Studies investigating the
malignant potential of GBPs are however often limited by numbers
with the majority including less than 100 patients [1,28,29].
Factors associated with an increased risk of malignancy are the
subject of debate, and a number have been proposed to be signif-
icant including; increasing age, the presence of gallstones, gall-
bladder wall thickening, rapid polyp growth, a sessile polyp on US,
smoking, Indian ethnicity, and symptomatic polyps [11,30e32].
Studies tend to agree that the larger the polyp the higher the risk of
malignancy, with some studies reporting a malignant risk of be-
tween 45 and 67% in polyps measuring between 10 and 15 mm
[2,7,14,30,31,33e48]. Studies are unclear whether gender is a risk
factor for malignancy [16,17,44,49,50].
Current literature advise that all GBPs greater than 10 mm in
diameter and/or causing symptoms should be surgically removed
[49]. There is no clear guidance on how best to manage those
patients not offered surgery at the outset. It has been suggested
GBPs less than 10 mm may be safely followed conservatively, yet
the frequency, duration and mode of surveillance remain unclear
[40]. The aim of current practice is to promote early detection and
treatment of potential or actual malignant polyps, as detection of
gallbladder carcinoma (GBC) at either stage 1 or 2 carries 95e99%
and 70% 5-year survival rates respectively [51]. In contrast GBC
discovered at stage 3 or 4 has only a 5e12% 5-year survival rate
[52].
Given the advances in radiological imaging, and the absence of
evidence-based guidance on follow-up surveillance protocols for
those patients not offered surgery at diagnosis, this review has
sought to further investigate evidence to inform practice. This
systematic review seeks to summarise the available literature and
provide guidance on the risk of an ultrasound detected gallbladder
polyp being either a true polyp or a gallbladder malignancy, and the
relevant risk factors to consider in such patients.2. Methods
2.1. Study protocol
A search of PubMed, DISCOVER (University of Liverpool), Scopus
and ScienceDirect was conducted using the keywords:
“Gallbladder” AND (“polyp” OR “polypoid lesion”)
The titles and abstracts were reviewed to establish potential
eligibility, based on the criteria listed in Table 1. Duplicate refer-
ences were excluded. All potentially relevant studies were retrieved
and assessed for eligibility and data quality by two reviewers. The
bibliographies of each included study were searched for other
potentially relevant studies. Studies were assessed for both rele-
vance and study quality.Table 1
Review inclusion criteria.
Inclusion criteria
 Papers including the keywords: “Gallbladder” AND (“polyp” OR “polypoid
lesion”)
 Language of paper: English
 Study subject: Human
 Publish date: Post 1950
 Studies assessing the risk of malignancy in cases of gallbladder polyps
 Studies assessing the natural history of gallbladder polyps when followed up
using Ultrasound.2.2. Study selection
Studies that were included described patients who had GBPs
detected by US. Studies were only included if they followed up the
natural history of GBPs, or assessed their risk of malignancy.
2.3. Data extraction
Data extraction was performed using a standardised data
extraction form. Information collected included the year of publi-
cation, country of origin, prevalence of GBPs, patients' de-
mographics, size and distribution of GBPs, indications for
cholecystectomy, histological results and follow up.
3. Results
3.1. Search results
The search identiﬁed 3744 references; following title review 474
abstracts were retrieved. Following dual author review 80 abstracts
were deemed potentially relevant and retrieved for full paper re-
view. Twelve papers were selected for inclusion in this systematic
review, ten from the initial search and two from a search of the
bibliographies of the eighty papers included for a full article review
(Fig. 1).
3.2. Descriptive analysis of included studies
3.2.1. Quality of studies and risk of bias
Only twelve papers met inclusion criteria. Follow-up varied
from eighteen months to eight years. Study group size varied from
34 to 18,610 patients. There was marked variance in study designs,
ﬁve were retrospective [27,32,40,48,53] and seven were prospec-
tive [1,22,28,29,54e56].
A diagnosis of GBP is subject to a degree of observer bias, and all
studies attempted to minimise observer bias by implementing
standardised criteria for the diagnosis of GBPs. Ansari et al. had four
sonographers/radiologists independently review patient US images
and combine the radiology reports [28]. Kratzer et al. had eight
trained assistants perform the US examinations [29].
Five studies retrospectively reviewed radiological reports to
assess patients followed-up by ultrasound [27,32,40,48,53]. Corwin
et al. reviewed the reports alongside the US images, with two au-
thors assessing each image, whilst in the four other studies radio-
logical reports were reviewed in isolation. The studies comment on
the difﬁculties of reviewing reports retrospectively, as the quality of
images is signiﬁcantly lower than those during live imaging.
Aldouri et al. did not speciﬁcally study GBPs [32]. They studied
the signiﬁcance of ethnicity with regards to a patient's risk of
gallbladder malignancy. As a result, there was some difﬁculty
relating their data to GBPs.
3.2.2. Prevalence of gallbladder polyps
Two of twelve studies were able to calculate the prevalence of
GBPs in their population. In a population of diabetic and non-
diabetic out-patients the prevalence was calculated as 6.7% [1]. In
a population of a rural German community the prevalence was
signiﬁcantly lower at 1.4% [29]. Both studies reported a higher
prevalence of GBPs in males.
3.2.3. Demographics of patients with gallbladder polyps
Ten of twelve studies reported the age range of their pop-
ulations. In nine studies the youngest patient was aged 14e25
years, and the oldest 74e94 [1,22,27,29,32,40,48,53,56]. The one
remaining study had a narrower age range, 35e63 years of age [54].
Search using terms: “Gallbladder” AND 
(“polyp” OR “polypoid lesion”)
Removal of duplicates and title review for 
inclusion/exclusion
3744
Abstracts reviewed for inclusion/exclusion 
criteria eligibility
474
Studies included in systematic review
12
Full review of paper by two reviewers
80
PubMed
230
DISCOVER
602
ScienceDirect
2361
Scopus
551
Fig. 1. Consort diagram showing systematic search process.
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Seven studies had a female predominance [22,27,32,40,48,53,56];
three studies had a male predominance [1,29,54]. The ratio of male
to female varies from 1:1.28 to 1.92:1. Collett et al. reported the
highest difference, though it should be noted this is in a study
population of only 38 [1].3.2.4. Gallbladder polyp description
Eleven of twelve studies reported the distribution of single and
multiple polyps. Nine initially reported between 50.7 and 89.5%
were single. One study reported that 59% of GBPsweremultiple at 5
years follow-up [1].
Eleven of twelve studies reported the size distribution of GBPs.
In eight studies, GBPs<5 mm accounted for over 50% of polyps.
GBPs >10 mm accounting for 0e12.3% of GBPs in ten studies and
44.8% in the last study. GBPs measuring 6e10 mm accounted for
16.4e42.1% of polyps.3.2.5. Follow-up
All twelve studies reported length of follow-up. Median follow-
up length varied from 1.4 to 5.9 years. The greatest range of follow-
up length in one study was 1.75e12 years, a similar range was re-
ported in a second study [40,53].
Ten of twelve studies reported the follow-up rate over the study
period. Four studies reported follow-up rates of 91.9e100% at the
end of the study period [22,28,54,55]. Three studies reported
follow-up rates of <50% by the end of the study period [40,53,56].
Nine of twelve studies recorded the appearance of GBPs on
follow-up, with 50.0e94.3% of GBPs were stable or decreased in
size on follow-up GBPs increasing in size on follow-up ranged from
5.0 to 26.5%. Seven of nine studies reported a signiﬁcant proportion
of GBPs, between 1.6 and 40.9%, were not visualised on follow-up
[22,29,48,53,55,56].3.2.6. Indications for cholecystectomy
Five of twelve studies reported indications for cholecystectomy
Table 2
Summary of histological results post-cholecystectomy.
Study Number of cholecystectomies Pseudopolypsa True GBPsa Malignant GBPsa No GBPsb
Pedersen et al. 13 7 (53.8%) 0 (0%) 0 (0%) 6 (46.2%)
Csendes et al. 27 24 (88.9%) 0 (0%) 0 (0%) 3 (11.1%)
Corwin et al. 42 10 (23.8%) 2 (4.8%) 0 (0%) 30c (71.4%)
Ansari et al. 31 24 (77.4%) 0 (0%) 2 (6.5%) 5 (16.1%)
Kratzer et al. 0
Ito et al. 80 46 (57.5%) 8 (10.0%) 0 (0%) 26 (32.5%)
Park et al. 172 139d (80.8%) 19 (11.0%) 14 (8.1%) 0 (0%)
Aldouri et al. Unclear 4
Collett et al. 0
Moriguchi et al. 4 4 (100%) 0 (0%) 0 (0%) 0 (0%)
Colecchia et al. 0
Sugiyama et al. 58 43 (74.1%) 4 (6.9%) 11 (19.0%) 0 (0%)
Total 427 (100%) 297 (69.6%) 33 (7.7%) 31 (7.3%) 70 (16.4%)
a As classiﬁed by Christensen and Ishak [5].
b Patients referred for cholecystectomy in which on histological examination no polyp was present.
c In one patient, polyp was seen at surgery but not at pathological examination.
d Park et al. did not speciﬁcally report the histological results of all cholecystectomies, for the sake of analysis, the results unaccounted for were presumed to be
pseudopolyps.
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[27,32,40,55], and in two studies no patient underwent cholecys-
tectomy [1,54].
GBP >10 mm and increase in GBP size on follow-up accounted
for over 50% of indications in three studies (51.9e66.0%) [28,29,56].
3.2.7. Histological results
Eight of twelve studies reported patients undergoing cholecys-
tectomy and recorded histological results (Table 2). Number of
cholecystectomies ranged from 4 to 169.
Adenocarcinomas were the only malignant GBPs, and with 31
patients accounting for 7.3% of histological diagnoses. The only True
GBPs reported were adenomas, and 33 patients were reported,
accounting for 7.7% of histological diagnoses.
Four of the eight studies reported adenomas, 2e19 patients
(1e11.0%) [27,48,53,55]. Four studies reported adenocarcinomas,
2e14 patients (6.5e19%) [27,28,32,55].
Seven studies reported Pseudopolyps, accounting for 69.6% of all
GBPs seen at histology (n ¼ 297). Five studies reported cases of no
GBP seen at histology, accounting for 16.4% of all cholecystectomies.
368 of 427(86.2%) cholecystectomies showed pseudopolyps or no
GBP.
3.3. Risk factors associated with true benign and malignant
gallbladder polyps
3.3.1. Size
The size of GBPs was the most commonly assessed risk factor. Of
64 patients of true and malignant polyps in this review, only one
patient was reported to be < 6 mm. This was a 4 mm adenocarci-
noma in a patient of Indian ethnic background [32].
The size of the reported malignant polyps was assessed where
possible (16 of 31 patients). Of these, just one (6.3%) patient was
<6mm in size, three (18.8%) patients were between 6 and 10mm in
size and twelve (75.0%) patients were 10 mm in size.
The size of the reported true polyps was assessed where
possible (14 out of 33 patients). No true polyps were reported to
be< 6mm, six (42.9%) were 6e10mm in size and eight (57.1%) were
10 mm in size.
Of the 5482 GBPs diagnosed in across these twelve studies, just
31 patients of malignant GBPs were reported, an incidence of 0.57%.
Patients with true GBPs accounted for an incidence of 0.60%
(n ¼ 33). Meaning that in patients with an ultrasound diagnosis of
GBPs and an indication for surgery, the actual incidence of either atrue or malignant GBP is just over 1%.
3.3.2. Single and multiple GBPs
Park et al. reported no signiﬁcant difference in risk of malignant
polyps in either single or multiple polyps(P value ¼ 0.64, 95% CI
0.425e1.692) [27]. Aldouri et al. concluded single GBPs above the
size of 10 mm were a signiﬁcant risk factor for gallbladder malig-
nancy [32]. Both adenomas reported by Corwin et al. were single
polyps [53]. Other studies within the review did not report whether
true and malignant polyps were single or multiple GBPs.
3.3.3. Growth of GBPs on follow-up
The growth of GBP on follow-up was a recognised risk factor for
malignancy within the studies, and was an indicator for cholecys-
tectomy in three studies, however, none of such polyps turned out
to be malignant [28,40,56]. Park et al. reported that 15 of 33 pa-
tients of true and malignant GBPs were <10 mm, and their growth
on follow-up was an indicator of potential malignancy [27].
3.3.4. Other potential risk factors
Aldouri et al. concluded that age >60 years, gallstones, gall-
bladder wall thickening and Indian ethnicity were factors associ-
ated with increased risk of gallbladder malignancy, but due to the
study design, the factors strongly associated with GBP malignancy
could not be assessed [32].
In contrast Park et al. reported that increasing age was not a risk
factor, though they concurred that gallstones signiﬁcantly
increased risk of malignant GBPs(P value ¼ 0.001, 95% CI
1.849e9.854) [27]. They also concluded that none of sex, diabetes
or other malignant diseases increased risk of malignant GBPs.
3.3.5. Risk factors
Established risk factors for true and malignant GBPs that are
considered proven in the studies included are:
 Size greater than 6 mm, with risk increasing with size.
 Growth of polyp during follow-up [27].
 Single polyp [27,32,53].
 Indian ethnic background.
Risk factors for true and malignant GBPs that may be signiﬁcant
but not yet ﬁrmly established are:
 Gallstones.
Fig. 2. Recommended guidelines for management of GBPs.
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 Cholecystitis or other persistent symptoms (abdominal pain).
 Age above 60 years
None of the included studies has discussed the risk of malignant
GBPs associated with primary sclerosing cholanigitis (PSC).4. Discussion
The twelve studies included in this systematic review, indicate
that the incidence of a true or malignant GBP is low, with GBPs
<6mmnot posing signiﬁcant malignant risk unless associated with
known risk factors. Prevalence of GBPs is low, reported at 1.4e6.7%
in this review. Subsequently, any study assessing GBPs must deal
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Included studies focused largely on the size and number of
polyps, and how this alters over follow-up. This approach, inad-
vertently, has made it difﬁcult to identify other signiﬁcant risk
factors associated with malignant GBPs. Furthermore; several
studies fail to fully report histological results, or even analyse the
size of true and malignant polyps.
The size of a GBP is largely regarded as the most signiﬁcant
indicator of potential malignancy, with studies concurring that
GBPs >10 mm in size warrant cholecystectomy [7,26,30,43,57e59].
Kubota et al. found that 88% of malignant polyps were over 10 mm,
and within this review, 75% of reported patients of adenocarci-
nomas were over 10 mm at diagnosis [30].
The prevalence of GBPs is estimated to be between 0.3 and 12.3%
based on a combination of surgical and population studies
[1,12e17,29]. Within this study, prevalence was reported to be
within this range (1.4% and 6.7%), though the ﬁgures differed by
5.3% [1,29]. With such a wide range in reported prevalence, it is
likely that population demographics have a largely unappreciated
impact on prevalence.
All studies in this review implemented standardised criteria for
diagnosis of GBPs, whether from the Author's experience or as
speciﬁed in previous studies [49,60e63]. Despite criteria, this re-
view indicates a signiﬁcant number of GBPs are not seen at histo-
logical examination post-cholecystectomy, with the incidence of no
GBP at histology accounting for 16.4% of all reported histological
results within this review. This concurs with ﬁndings of previous
studies, with author's theorising that a signiﬁcant number of GBPs
seen on US are in fact gallstones, adherent sludge or cholesterol
polyps that slough off prior to surgery [14,26,28,40,44,48,54,56].
Of patients where a GBP seen at US examination was present at
histology, 83.2% of GBPs were diagnosed as Pseudopolyps. Themost
common of which were cholesterol polyps (114 cases). This concurs
with previous studies that indicate cholesterol polyps may account
for over 70% of all GBPs seen on US examination [26,33,63,64].
Previous studies have reported high incidences of malignancy in
GBPs >10 mm, yet this review reported malignancy in just 7.55% of
all GBPs >10 mm [65,66]. With this review reporting that
GBPs>10 mm have a very low incidence, just 4.17% of GBPs, indi-
cating that the risk of malignancy in incidentally US detected GBPs
could be potentially overestimated.
Current literature advise cholecystectomy for all GBPs >10 mm
and US follow-up for GBPs <10 mm [15,26,44,67,68]. Length of
follow-up is ill-deﬁned, with current evidence only indicating it
should be ‘lengthy’, commonly at 6 or 12 month intervals
[15,26,44,67,68]. This review demonstrated median follow-up of
1.4e5.9 years. Park et al. reported a patient in which it took seven
years for the growth of a neoplastic GBP to be recognised, though
the majority of neoplastic GBPs reported were detected much
earlier, either at baseline or in early follow-up [27]. A recent report
concluded that dysplasia to adenocarcinoma transformation may
take over ten years, supporting long periods of follow-up for GBPs
[69].
GBPs are almost exclusively diagnosed and followed-up by ul-
trasonography, despite multiple studies challenging its ability to do
so accurately, as it remains the most appropriate and cost-effective
method of screening [25,70,71]. Sugiyama et al. reported that US
correctly diagnosed GBPs prior to cholecystectomy in 76% of 58
cases, though endoscopic ultrasound (EUS) demonstrated greater
accuracy and was correct in 97% of cases [55]. Higher accuracies of
US have been recorded; Yang et al. reported false positives in just 6%
of their patient population [7]. Conversely other studies have re-
ported US accuracy to be as low as 47% [13,49].
With the accuracy of US in assessment of GBPs being ques-
tioned, conﬁrmed by failure to ﬁnd the GBPs reported by US at asigniﬁcant number of histological examinations, it seems prudent
to suggest utilization of other imaging modalities such as Magnetic
Resonance Cholangio-Pancreatography (MRCP), Positron Emission
Tomography -Computed Tomography (PET-CT), or the reportedly
higher accuracy of EUS in assessment of GBPs, especially where
cholecystectomy is being considered. EUS may be invasive but does
not carry the same risks as cholecystectomy [72]. In contrast, whilst
risks of cholecystectomy are small, they are signiﬁcant, including
mortality resulting from vessel, bowel a bile duct injuries (reported
incidence 0.3e1%) [73e75].
The major limitation of this review was the conﬁdence with
which data from the twelve studies could be comparatively ana-
lysed. A lack of uniform reporting of data hampered inter-study
comparison, which made it difﬁcult to assess GBP demographics,
and more importantly to accurately assess the size range within
which true and malignant GBPs were measured. The retrospective
design of ﬁve of the studies also limits this review, as all, or a
number of, patients with GBPs were reviewed/followed-up with
sole use of radiological reports, without US images [27,32,48,53,56].
Though even in cases where US images were reviewed, it is noted
they have suboptimal quality compared to those during live-
imaging [56].
On the basis of the current evidence obtained from the available
literature, it is very difﬁcult to design a robust, evidence based
management and follow-up plan for patients with US detected
GBPs. Nevertheless, a proposed ﬂowchart for management of GBPs
has been designed to aid in the future management of this topical,
yet controversial pathology (Fig. 2).
Despite the limitations of the available literature, this is the
largest review of studies examining the natural history of ultra-
sonographically diagnosed GBPs to date.
5. Conclusion
The potential malignant risk of GBPs is low, but missing a GBC is
potentially catastrophic. By applying the known predictors of ma-
lignancy, and utilising advanced methods of assessment, such as
EUS, it should be possible to more effectively inform the manage-
ment of patients with GBPs. Based on this review of the evidence,
and recent recommendations by similar review [76], the authors
recommend that a cholecystectomy should be considered in any
patient with a GBP of size of 10 mm or greater. For polyps of less
than 10 mm, follow-up with Ultrasound imaging should be carried
out on a six monthly basis, for at least 2 years until the stability of a
GBP is ﬁrmly established (Fig. 2). If there is evidence of growth, the
option of cholecystectomy should be discussed with the patient.
Ideally, where there is uncertainty, the patients should be managed
within a recognised hepatobiliary centre with expertise in the
management of biliary tract malignancy.
Ethical approval
Not applicable.
Sources of funding
None.
Author contribution
Mohamed Elmasry: Study concepts, Study design, Data acqui-
sition, Quality control of data and algorithms, Data analysis and
interpretation, Statistical analysis, Manuscript preparation, Manu-
script editing and Manuscript review.
Don Lindop: Study concepts, Study design, Data acquisition,
M. Elmasry et al. / International Journal of Surgery 33 (2016) 28e3534Quality control of data and algorithms, Data analysis and inter-
pretation, Statistical analysis, Manuscript preparation, Manuscript
editing and Manuscript review.
Declan Dunne: Study concepts, Study design, Data acquisition,
Quality control of data and algorithms, Data analysis and inter-
pretation, Manuscript preparation, Manuscript editing and Manu-
script review.
Graeme Poston: Manuscript editing and Manuscript review.
Hassan Malik: Manuscript editing and Manuscript review.
Stephen Fenwick: Study concepts, Study design, Manuscript
preparation, Manuscript editing and Manuscript review.
Conﬂict of interest
The authors declare no conﬂict of interest.
Trial registry number
Not applicable.
Guarantor
Mohamed Elmasry.
Stephen Fenwick.
References
[1] J.A. Collett, R.B. Allan, R.J. Chisholm, I.R. Wilson, M.J. Burt, B.A. Chapman,
Gallbladder polyps: prospective study, J. Ultrasound Med. Ofﬁcial J. Am. Inst.
Ultrasound Med. 17 (4) (1998) 207e211.
[2] X.-J. Sun, J.-S. Shi, Y. Han, J.-S. Wang, H. Ren, Diagnosis and treatment of
polypoid lesions of the gallbladder: report of 194 cases, Hepatobiliary Pan-
creat. Dis. Int. HBPD INT 3 (4) (2004) 591e594.
[3] W. Blonski, K.R. Reddy, Evaluation of nonmalignant liver masses, Curr. Gas-
troenterol. Rep. 8 (1) (2006) 38e45. Epub 2006/03/03.
[4] B.Y. Choi, M.H. Nguyen, The diagnosis and management of benign hepatic
tumors, J. Clin. Gastroenterology 39 (5) (2005) 401e412. Epub 2005/04/09.
[5] A.H. Christensen, K.G. Ishak, Benign tumors and pseudotumors of the gall-
bladder. Report of 180 cases, Arch. Pathol. 90 (5) (1970) 423e432.
[6] Y. Shirai, T. Ohtani, K. Hatakeyama, Is laparoscopic cholecystectomy recom-
mended for large polypoid lesions of the gallbladder? Surg. Laparosc. Endosc.
7 (5) (1997 Oct) 435e436.
[7] H.L. Yang, Y.G. Sun, Z. Wang, Polypoid lesions of the gallbladder: diagnosis and
indications for surgery, Br. J. Surg. 79 (3) (1992) 227e229.
[8] I.I. Wistuba, J.F. Miquel, A.F. Gazdar, J. Albores-Saavedra, Gallbladder ade-
nomas have molecular abnormalities different from those present in gall-
bladder carcinomas, Hum. Pathol. 30 (1) (1999) 21e25.
[9] I. Roa, X. de Aretxabala, J.C. Araya, M. Villaseca, J. Roa, P. Guzman, Incipient
gallbladder carcinoma. Clinical and pathological study and prognosis in 196
cases, Rev. Med. Chil. 129 (10) (2001) 1113e1120.
[10] S. Kozuka, N. Tsubone, A. Yasui, K. Hachisuka, Relation of adenoma to carci-
noma in the gallbladder, Cancer 50 (10) (1982) 2226e2234.
[11] A. Koga, S. Yamauchi, Y. Izumi, N. Hamanaka, Ultrasonographic detection of
early and curable carcinoma of the gallbladder, Br. J. Surg. 72 (9) (1985)
728e730.
[12] S. Afzal, V.B. Kristiansen, J. Rosenberg, Gallbladder polyps, Ugeskr. Laeger 163
(37) (2001) 5003e5006.
[13] L.J. Damore 2nd, C.H. Cook, K.L. Fernandez, J. Cunningham, E.C. Ellison,
W.S. Melvin, Ultrasonography incorrectly diagnoses gallbladder polyps, Surg.
Laparosc. Endosc. Percutan Tech. 11 (2) (2001) 88e91.
[14] D. Chattopadhyay, R. Lochan, S. Balupuri, B.R. Gopinath, K.S. Wynne, Outcome
of gall bladder polypoidal lesions detected by transabdominal ultrasound
scanning: a nine year experience, World J. Gastroenterol. 11 (14) (2005)
2171e2173.
[15] R.P. Myers, E.A. Shaffer, P.L. Beck, Gallbladder polyps: epidemiology, natural
history and management, Can. J. Gastroenterol. 16 (3) (2002) 187e194.
[16] T. Jorgensen, K.H. Jensen, Polyps in the gallbladder. A prevalence study, Scand.
J. Gastroenterol. 25 (3) (1990) 281e286.
[17] K. Segawa, T. Arisawa, Y. Niwa, T. Suzuki, Y. Tsukamoto, H. Goto, et al.,
Prevalence of gallbladder polyps among apparently healthy Japanese: ultra-
sonographic study, Am. J. Gastroenterol. 87 (5) (1992) 630e633.
[18] M.M. Ozmen, R.V. Patankar, S. Hengirmen, M.C. Terzi, Epidemiology of gall-
bladder polyps, Scand. J. Gastroenterology 29 (5) (1994) 480.
[19] N. Heyder, E. Gunter, J. Giedl, A. Obenauf, E.G. Hahn, Polypoid lesions of the
gallbladder, Dtsch. Med. Wochenschr 115 (7) (1990) 243e247.
[20] W.R. Lin, D.Y. Lin, D.I. Tai, S.Y. Hsieh, C.Y. Lin, I.S. Sheen, et al., Prevalence ofand risk factors for gallbladder polyps detected by ultrasonography among
healthy Chinese: analysis of 34 669 cases, J. Gastroenterology Hepatology 23
(6) (2008) 965e969.
[21] M. Okamoto, H. Okamoto, F. Kitahara, K. Kobayashi, K. Karikome, K. Miura, et
al., Ultrasonographic evidence of association of polyps and stones with gall-
bladder cancer, Am. J. Gastroenterology 94 (2) (1999) 446e450.
[22] H. Moriguchi, J. Tazawa, Y. Hayashi, H. Takenawa, E. Nakayama, F. Marumo, et
al., Natural history of polypoid lesions in the gall bladder, Gut 39 (6) (1996)
860e862.
[23] K. Shinchi, S. Kono, S. Honjo, K. Imanishi, T. Hirohata, Epidemiology of gall-
bladder polyps: an ultrasonographic study of male self-defense ofﬁcials in
Japan, Scand. J. Gastroenterology 29 (1) (1994) 7e10.
[24] Y. Hayashi, J.H. Liu, H. Moriguchi, H. Takenawa, J. Tazawa, E. Nakayama, et al.,
Prevalence of polypoid lesions of the gallbladder in urban and rural areas of
Japan: comparison between 1988 and 1993, J. Clin. Gastroenterology 23 (2)
(1996) 158e159.
[25] M. Pandey, A.K. Khatri, B.P. Sood, R.C. Shukla, V.K. Shukla, Cholecystosono-
graphic evaluation of the prevalence of gallbladder diseases. A university
hospital experience, Clin. Imaging 20 (4) (1996) 269e272.
[26] K.F. Lee, J. Wong, J.C.M. Li, P.B.S. Lai, Polypoid lesions of the gallbladder, Am. J.
Surg. 188 (2) (2004) 186e190.
[27] J.Y. Park, S.P. Hong, Y.J. Kim, H.J. Kim, H.M. Kim, J.H. Cho, et al., Long-term
follow up of gallbladder polyps, J. Gastroenterol. Hepatol. 24 (2) (2009)
219e222.
[28] S.M. Ansari, S. Banu, M.A. Awal, A.B. Siddique, M.M. Alam, Polypoid gall
bladder lesions: is it necessary for immediate surgery? Bangladesh Med. Res.
Counc. Bull. 33 (2) (2007) 44e47.
[29] W. Kratzer, M.M. Haenle, A. Voegtle, R.A. Mason, A.S. Akinli, K. Hirschbuehl, et
al., Ultrasonographically detected gallbladder polyps: a reason for concern? A
seven-year follow-up study, BMC Gastroenterol. 8 (41) (2008) 8e41.
[30] K. Kubota, Y. Bandai, T. Noie, Y. Ishizaki, M. Teruya, M. Makuuchi, How should
polypoid lesions of the gallbladder be treated in the era of laparoscopic
cholecystectomy? Surgery 117 (5) (1995) 481e487.
[31] O. Ishikawa, H. Ohhigashi, S. Imaoka, A. Nakaizumi, T. Kitamura, Y. Sasaki, et
al., The difference in malignancy between pedunculated and sessile polypoid
lesions of the gallbladder, Am. J. Gastroenterol. 84 (11) (1989) 1386e1390.
[32] A.Q. Aldouri, H.Z. Malik, J. Waytt, S. Khan, K. Ranganathan, S. Kummaraganti,
et al., The risk of gallbladder cancer from polyps in a large multiethnic series,
Eur. J. Surg. Oncol. 35 (1) (2009) 48e51.
[33] A. Koga, K. Watanabe, T. Fukuyama, S. Takiguchi, F. Nakayama, Diagnosis and
operative indications for polypoid lesions of the gallbladder, Arch. Surg. 123
(1) (1988) 26e29.
[34] M.A. Pejic, D.J. Milic, Surgical treatment of polypoid lesions of gallbladder, Srp.
Arh. za Celok. Lek. 131 (7e8) (2003) 319e324. Epub 2003/12/25. Hirurski
tretman polipoidnih lezija zucne kese.
[35] G. Catania, G. Benfatto, F. Cardi, C. Puleo, F. Catalano, L. Tenaglia, Polypoid
lesions of the gallbladder: indications for surgical treatment, Chir. Ital. 55 (6)
(2003) 865e870. Epub 2004/01/17. Le lesioni polipoidi della colecisti: indi-
cazioni all'intervento chirurgico.
[36] B.H. Cha, J.H. Hwang, S.H. Lee, J.E. Kim, J.Y. Cho, H. Kim, et al., Pre-operative
factors that can predict neoplastic polypoid lesions of the gallbladder, World J.
Gastroenterol. 17 (17) (2011) 2216e2222. Epub 2011/06/03.
[37] Z.M. He, X.Q. Hu, Z.X. Zhou, Considerations on indications for surgery in pa-
tients with polypoid lesion of the gallbladder, Di 1 jun yi da xue xue bao ¼
Acad. J. First Med. Coll. PLA 22 (10) (2002) 951e952. Epub 2002/10/16.
[38] X.Y. Li, C.J. Zheng, J. Chen, J.X. Zhang, Diagnosis and treatment of polypoid
lesion of the gallbladder, Zhongguo yi xue ke xue yuan xue bao Acta Acad.
Med. Sin. 25 (6) (2003) 689e693. Epub 2004/01/13.
[39] C.N. Yeh, Y.Y. Jan, T.C. Chao, M.F. Chen, Laparoscopic cholecystectomy for
polypoid lesions of the gallbladder: a clinicopathologic study, Surg. Laparosc.
Endosc. Percutan Tech. 11 (3) (2001) 176e181. Epub 2001/07/11.
[40] A. Csendes, A.M. Burgos, P. Csendes, G. Smok, J. Rojas, Late follow-up of
polypoid lesions of the gallbladder smaller than 10 mm, Ann. Surg. 234 (5)
(2001) 657e660.
[41] S. Bang, Natural course and treatment strategy of gallbladder polyp, Korean J.
Gastroenterology ¼ Taehan Sohwagi Hakhoe chi 53 (6) (2009) 336e340. Epub
2009/06/27.
[42] S.R. Shin, J.K. Lee, K.H. Lee, K.T. Lee, J.C. Rhee, K.T. Jang, et al., Can the growth
rate of a gallbladder polyp predict a neoplastic polyp? J. Clin. Gastroenterology
43 (9) (2009) 865e868. Epub 2009/04/29.
[43] K. Chijiiwa, M. Tanaka, Polypoid lesion of the gallbladder: indications of car-
cinoma and outcome after surgery for malignant polypoid lesion, Int. Surg. 79
(2) (1994) 106e109. Epub 1994/04/01.
[44] K.S. Mainprize, J.M. Gilbert, S.W.T. Gould, Surgical management of polypoid
lesions of the gallbladder, Br. J. Surg. 87 (4) (2000) 414e417.
[45] C. Terzi, S. Sokmen, S. Seckin, L. Albayrak, M. Ugurlu, Polypoid lesions of the
gallbladder: report of 100 cases with special reference to operative in-
dications, Surgery 127 (6) (2000) 622e627. Epub 2000/06/07.
[46] M.D. Zielinski, T.D. Atwell, P.W. Davis, M.L. Kendrick, F.G. Que, Comparison of
surgically resected polypoid lesions of the gallbladder to their pre-operative
ultrasound characteristics, J. Gastrointest. Surg. 13 (1) (2009) 19e25. Epub
2008/10/31.
[47] W. Kwon, J.Y. Jang, S.E. Lee, D.W. Hwang, S.W. Kim, Clinicopathologic features
of polypoid lesions of the gallbladder and risk factors of gallbladder cancer,
J. Korean Med. Sci. 24 (3) (2009) 481e487. Epub 2009/06/23.
M. Elmasry et al. / International Journal of Surgery 33 (2016) 28e35 35[48] H. Ito, L.E. Hann, M. D'Angelica, P. Allen, Y. Fong, R.P. Dematteo, et al., Polypoid
lesions of the gallbladder: diagnosis and followup, J. Am. Coll. Surg. 208 (4)
(2009) 570e575.
[49] A. Ozdemir, A. Ozenc, S. Bozoklu, T. Cosk¸un, Ultrasonography in the diagnosis
of gallbladder polyps, Br. J. Surg. 80 (3) (1993), 345-.
[50] C.Y. Chen, C.L. Lu, F.Y. Chang, S.D. Lee, Risk factors for gallbladder polyps in the
Chinese population, Am. J. Gastroenterol. 92 (11) (1997) 2066e2068. Epub
1997/11/15.
[51] K. Ouchi, J. Mikuni, Y. Kakugawa, Laparoscopic cholecystectomy for gall-
bladder carcinoma: results of a Japanese survey of 498 patients,
J. Hepatobiliary Pancreat. Surg. 9 (2) (2002) 256e260.
[52] H. Ito, E. Matros, D.C. Brooks, R.T. Osteen, M.J. Zinner, R.S. Swanson, et al.,
Treatment outcomes associated with surgery for gallbladder cancer: a 20-year
experience, J. Gastrointest. Surg. 8 (2) (2004) 183e190.
[53] M.T. Corwin, B. Siewert, R.G. Sheiman, R.A. Kane, Incidentally detected gall-
bladder polyps: is follow-up necessary?eLong-term clinical and US analysis of
346 patients, Radiology 258 (1) (2011) 277e282.
[54] A. Colecchia, A. Larocca, E. Scaioli, M.L. Bacchi-Reggiani, A.R. Di Biase,
F. Azzaroli, et al., Natural history of small gallbladder polyps is benign: evi-
dence from a clinical and pathogenetic study, Am. J. Gastroenterol. 104 (3)
(2009) 624e629.
[55] M. Sugiyama, Y. Atomi, T. Yamato, Endoscopic ultrasonography for differential
diagnosis of polypoid gall bladder lesions: analysis in surgical and follow up
series, Gut 46 (2) (2000) 250e254.
[56] M.R. Pedersen, C. Dam, S.R. Rafaelsen, Ultrasound follow-up for gallbladder
polyps less than 6 mm may not be necessary, Dan. Med. J. 59 (10) (2012).
[57] C.D. Johnson, Polypoid lesions of the gall bladder, Gut 41 (4) (1997) 578. Epub
1997/12/10.
[58] A.W. Majeed, A.G. Johnson, Gallbladder polyps are a common ultrasono-
graphic ﬁnding, J. Am. Coll. Surg. 181 (2) (1995) 189. Epub 1995/08/01.
[59] H. Shinkai, W. Kimura, T. Muto, Surgical indications for small polypoid lesions
of the gallbladder, Am. J. Surg. 175 (2) (1998) 114e117. Epub 1998/03/27.
[60] A.H. Ruhe, J.P. Zachman, B.D. Mulder, A.E. Rime, Cholesterol polyps of the
gallbladder: ultrasound demonstration, J. Clin. Ultrasound 7 (5) (1979)
386e388.
[61] M. Sugiyama, Y. Atomi, A. Kuroda, T. Muto, N. Wada, Large cholesterol polyps
of the gallbladder: diagnosis by means of US and endoscopic US, Radiology
196 (2) (1995) 493e497.
[62] M. Sugiyama, X.Y. Xie, Y. Atomi, M. Saito, Differential diagnosis of small
polypoid lesions of the gallbladder: the value of endoscopic ultrasonography,Ann. Surg. 229 (4) (1999) 498e504.
[63] J.E. Lichtenstein, The gallbladder: what if it's not stone disease? Semin.
Roentgenol. 26 (3) (1991) 209e215.
[64] C. Wolpers, Gallbladder polyps and gallbladder stones, Dtsch. Med.
Wochenschr 114 (49) (1989) 1905e1912.
[65] M. Kidney, R. Goiney, P.L. Cooperberg, Adenomyomatosis of the gallbladder: a
pictorial exhibit, J. ultrasound Med. Ofﬁcial J. Am. Inst. Ultrasound Med. 5 (6)
(1986) 331e333.
[66] J. Albores-Saavedra, C.J. Vardaman, F. Vuitch, Non-neoplastic polypoid lesions
and adenomas of the gallbladder, Pathol. Annu. 28 Pt (1) (1993) 145e177.
[67] M.E. Tublin, Question and answer. Sonographic follow-up of patients with
gallbladder polyps, AJR Am. J. Roentgenol. 177 (2) (2001) 467. Epub 2001/07/
20.
[68] R.A. Boulton, D.H. Adams, Gallbladder polyps: when to wait and when to act,
Lancet 349 (9055) (1997) 817. Epub 1997/03/22.
[69] I. Roa, X. de Aretxabala, J.C. Araya, J. Roa, Preneoplastic lesions in gallbladder
cancer, J. Surg. Oncol. 93 (8) (2006) 615e623.
[70] Y. Tsuchiya, Early carcinoma of the gallbladder: macroscopic features and US
ﬁndings, Radiology 179 (1) (1991) 171e175.
[71] H. Onoyama, M. Yamamoto, M. Takada, T. Urakawa, T. Ajiki, I. Yamada, et al.,
Diagnostic imaging of early gallbladder cancer: retrospective study of 53
cases, World J. Surg. 23 (7) (1999) 708e712.
[72] G.M. Eisen, T.H. Baron, J.A. Dominitz, D.O. Faigel, J.L. Goldstein, J.F. Johanson, et
al., Complications of upper GI endoscopy, Gastrointest. Endosc. 55 (7) (2002)
784e793.
[73] D.R. Fletcher, M.S. Hobbs, P. Tan, L.J. Valinsky, R.L. Hockey, T.J. Pikora, et al.,
Complications of cholecystectomy: risks of the laparoscopic approach and
protective effects of operative cholangiography: a population-based study,
Ann. Surg. 229 (4) (1999) 449e457.
[74] M.C. Richardson, G. Bell, G.M. Fullarton, Incidence and nature of bile duct
injuries following laparoscopic cholecystectomy: an audit of 5913 cases. West
of Scotland Laparoscopic Cholecystectomy Audit Group, Br. J. Surg. 83 (10)
(1996) 1356e1360. Epub 1996/10/01.
[75] L. Krahenbuhl, G. Sclabas, M.N. Wente, M. Schafer, R. Schlumpf, M.W. Buchler,
Incidence, risk factors, and prevention of biliary tract injuries during laparo-
scopic cholecystectomy in Switzerland, World J. Surg. 25 (10) (2001)
1325e1330.
[76] Management and diagnosis of gallbladder polyps: a systematic review, Lan-
genbeck's Archives Surg. 400 (4) (May 2015) 455e462.
